MAIA Biotechnology (MAIA) Other financing activities (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Other financing activities of $38549.0 for Q1 2026, up 2.8% year-over-year from $37500.0 in Q1 2025, and down 44.93% quarter-over-quarter from $70000.0 in Q4 2025.
MAIA Biotechnology (MAIA) Other financing activities (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Other financing activities for 5 consecutive years, with $38549.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 2.8% year-over-year to $38549.0; the TTM figure through Mar 2026 stood at $224042.0 (up 87.45% YoY), while the FY2025 annual figure was $901578.0, down 91.08% from the prior year.
- Other financing activities eased to $38549.0 in Q1 2026 per MAIA's latest filing, from $70000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $337700.0 in Q2 2022 and bottomed at -$319700.0 in Q3 2022.
- Historically, Other financing activities has averaged $52297.0 across 4 years, with a median of $42674.5 in 2024.
- Annual changes were most pronounced in 2022 — Other financing activities slumped 96.51% — and 2025, when it surged 2196.08%.
- MAIA Biotechnology's Other financing activities stood at $18300.0 in 2022, then surged by 155.74% to $46800.0 in 2024, then soared by 49.57% to $70000.0 in 2025, then tumbled by 44.93% to $38549.0 in 2026.
- Business Quant data shows MAIA's Other financing activities at $38549.0 in Q1 2026, $70000.0 in Q4 2025, and $115493.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,549.00 |
| Mar 31, 2026 | 38,549.00 |
| Dec 31, 2025 | 70,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Jun 30, 2025 | 115,493.00 |
| Jun 30, 2025 | 115,493.00 |
| Mar 31, 2025 | 37,500.00 |
| Mar 31, 2025 | 37,500.00 |
| Dec 31, 2024 | 46,800.00 |
| Dec 31, 2024 | 46,800.00 |
| Sep 30, 2024 | 30,192.00 |
| Sep 30, 2024 | 30,192.00 |
| Jun 30, 2024 | 5,030.00 |
| Jun 30, 2024 | 5,030.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2022 | 18,300.00 |
| Dec 31, 2022 | 18,300.00 |
| Sep 30, 2022 | -319,700.00 |
| Sep 30, 2022 | -319,700.00 |